Amedeo Smart

Free Medical Literature Service

 

Amedeo

Thoracic Surgery
  Free Subscription

Articles published in
Catheter Cardiovasc Interv
    May 2024
  1. THACH R, Blank R, Lin C
    Hemodynamics of low-pressure cardiac tamponade: An illustrative case report.
    Catheter Cardiovasc Interv. 2024;103:1062-1068.
    >> Share

  2. ENGEL GONZALEZ P, Gregerson S, Mahmood S, Brooks C, et al
    Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions.
    Catheter Cardiovasc Interv. 2024;103:1023-1034.
    >> Share

  3. CASE BC, Bazarbashi N, Johnson A, Rogers T, et al
    A novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique.
    Catheter Cardiovasc Interv. 2024;103:917-923.
    >> Share

  4. DONAHUE CL, Westman CL, Faanes BL, Qureshi AM, et al
    Finite element modeling with patient-specific geometry to assess clinical risks of percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2024;103:924-933.
    >> Share

  5. JOOSEN RS, Voskuil M, Krings GJ, Handoko ML, et al
    The impact of unilateral pulmonary artery stenosis on right ventricular to pulmonary arterial coupling in patients with transposition of the great arteries.
    Catheter Cardiovasc Interv. 2024;103:943-948.
    >> Share

  6. WANG W, Itagaki S, Egorova N
    Minimally invasive procedures for right side infective endocarditis: A targeted literature review.
    Catheter Cardiovasc Interv. 2024;103:1050-1061.
    >> Share

  7. YE C, Ma X, Shi B, Yan R, et al
    Obesity is associated with acute kidney injury in ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention: A national representative cohort study.
    Catheter Cardiovasc Interv. 2024;103:897-908.
    >> Share


  8. Correction to "Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study".
    Catheter Cardiovasc Interv. 2024;103:1078.
    >> Share

    April 2024
  9. DAMARKUSUMA A, Johar S, Patel B, Yung CC, et al
    Using Ping-pong technique along with rapid inflate-deflate ballooning to solve total left main occlusion during transcatheter aortic valve replacement procedure.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31059.
    >> Share

  10. SPIRITO A, Gao M, Sartori S, Vogel B, et al
    Prevalence and prognostic impact of complex percutaneous coronary intervention among octogenarians.
    Catheter Cardiovasc Interv. 2024 Apr 19. doi: 10.1002/ccd.31055.
    >> Share

  11. REMPAKOS A, Alexandrou M, Mutlu D, Choi JW, et al
    Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Apr 17. doi: 10.1002/ccd.31045.
    >> Share

  12. BUCHANAN CE, Iskander M, Anwaruddin S, Mason PJ, et al
    Novel valve-in-surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN).
    Catheter Cardiovasc Interv. 2024 Apr 8. doi: 10.1002/ccd.31038.
    >> Share

  13. BOIAGO M, Bellamoli M, De Biase C, Beneduce A, et al
    Three-year clinical outcomes after transcatheter aortic valve implantation in patients with bicuspid aortic disease: Comparison between self-expanding and balloon-expandable valves.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31041.
    >> Share

  14. TEBAR D, Carrillo X, Garcia Del Blanco B, Gomez-Hospital JA, et al
    Experience with the ACURATE neo and neo2 transcatheter aortic valves in Spain. The PRECISA (PRospective Evaluation Complementing Investigation with ACURATE devices) registry.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31032.
    >> Share

  15. OZTAS DM, Ozdemir E, Bauernschmitt R, Ugurlucan M, et al
    Transcatheter aortic valve implantation for pure aortic insufficiency in a patient following David-type aortic valve-sparing root replacement after aortic dissection-A successful off-label procedure.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31033.
    >> Share

  16. KORNOWSKI R
    Extent of cardiac damage before transcatheter aortic valve replacement: Beyond aortic stenosis per se.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31031.
    >> Share

  17. BAEKKE PS, Gran LL, Jorgensen TH, Ghattas A, et al
    Extent of cardiac damage and hospitalization burden in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31015.
    >> Share

  18. AL-OGAILI A, Alexandrou M, Rempakos A, Mutlu D, et al
    Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31019.
    >> Share

  19. LEI J, Pu H, Zhang L, Zeng C, et al
    Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: A single-arm observational study.
    Catheter Cardiovasc Interv. 2024;103:752-757.
    >> Share

    March 2024
  20. BIANCARI F, Makikallio T
    Hospital racial composition and outcomes after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Mar 29. doi: 10.1002/ccd.31022.
    >> Share

  21. BASMAN C, Landers D, Kliger C, Rodriguez-Barragan K, et al
    Balloon rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Mar 28. doi: 10.1002/ccd.31029.
    >> Share

  22. GIORDANO A, Biondi-Zoccai G
    Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with!
    Catheter Cardiovasc Interv. 2024 Mar 20. doi: 10.1002/ccd.31011.
    >> Share

  23. SETO AH, Yau P
    Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
    Catheter Cardiovasc Interv. 2024 Mar 17. doi: 10.1002/ccd.31014.
    >> Share

  24. POOMMIPANIT P, Tashtish N
    The utility of guide catheter extensions (GCE) in coronary interventions and specifically chronic total occlusion (CTO) interventions.
    Catheter Cardiovasc Interv. 2024 Mar 15. doi: 10.1002/ccd.31012.
    >> Share

  25. HANSON I, Goldstein JA
    Trans-catheter repair of tricuspid regurgitation following left heart valve surgery: Expansion of the interventionist portfolio.
    Catheter Cardiovasc Interv. 2024 Mar 15. doi: 10.1002/ccd.31013.
    >> Share

  26. EL SHERBINI AH, Servito M, Zidan A, Elsherif S, et al
    Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: A meta-analysis.
    Catheter Cardiovasc Interv. 2024 Mar 10. doi: 10.1002/ccd.30985.
    >> Share

  27. ROSS DS, Nogic J, Cong H, Nuzzi V, et al
    Ultrasound-guided deployment of ProGlide device in transfemoral transcatheter aortic valve implantation and risk reduction of vascular complications: A propensity-matched cohort study.
    Catheter Cardiovasc Interv. 2024 Mar 7. doi: 10.1002/ccd.30999.
    >> Share

  28. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    >> Share

  29. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    >> Share

  30. DENBY K, Zaczkiewicz M, Banthiya S, Mashayekhi K, et al
    Understanding large vessel perforation requiring treatment with covered stent implantation: A case series.
    Catheter Cardiovasc Interv. 2024;103:570-579.
    >> Share

  31. KIEKENAP J, Sun X, Hao Y, Steitz M, et al
    Long-term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model.
    Catheter Cardiovasc Interv. 2024;103:597-606.
    >> Share

  32. PAN W, Zhou D, Hijazi ZM, Qureshi SA, et al
    2024 Statement from Asia expert operators on transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2024;103:660-669.
    >> Share

  33. ALDOSS O, Porayette P, Mohammad Nijres B
    Bilateral Harmony valve placement in branch pulmonary arteries.
    Catheter Cardiovasc Interv. 2024;103:612-617.
    >> Share

  34. UZUN F, Guner A, Demirci G, Ciloglu K, et al
    Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
    Catheter Cardiovasc Interv. 2024;103:511-522.
    >> Share

  35. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    >> Share

  36. CHAUS A, Uretsky BF
    Treating cardiac tamponade due to malignant effusion with percutaneous balloon pericardiotomy: Back to the future.
    Catheter Cardiovasc Interv. 2024;103:682-683.
    >> Share

  37. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    >> Share

  38. PARK WY, Kim GB, Lee SY, Kim AY, et al
    The adaptability of the Pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease.
    Catheter Cardiovasc Interv. 2024;103:587-596.
    >> Share

    February 2024
  39. PENG S, Rempakos A, Mastrodemos OC, Rangan BV, et al
    Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30994.
    >> Share

  40. ANDREKA J, Sasi V, Toth GG, Ruzsa Z, et al
    Stent graft implantation from distal radial access-A novel way to treat femoral access site complication during transcatheter aortic valve replacement: A case report.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31001.
    >> Share

  41. HAKGOR A, Dursun A, Kahraman BC, Yazar A, et al
    Prognostic impact of main pulmonary artery to ascending aorta diameter ratio in patients with severe aortic stenosis underwent transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31000.
    >> Share

  42. BOUSSOFARA A, Godin M, Canville A, Baala B, et al
    Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30969.
    >> Share

  43. MAIANI S, Nardi G, Di Mario C, Meucci F, et al
    Patient-specific computer simulation of transcatheter aortic valve replacement in patients with previous mechanical mitral prosthesis: A case series.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30984.
    >> Share

  44. HASHEM A, Goldsweig AM
    Funny things are everywhere: Combatting geographic disparities in aortic stenosis care.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30971.
    >> Share

  45. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    >> Share

  46. CHEN Y, Xiao Y, Huang R, Jiang F, et al
    Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30970.
    >> Share

  47. WANG Y, Zhai M, Mao Y, Yang T, et al
    Transcatheter tricuspid valve replacement for functional tricuspid regurgitation after left-sided valve surgery: A single-center experience.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30972.
    >> Share

  48. KELLEY BP, Glasco S, Sang CJ 3rd, Yoo B, et al
    To flip or not: Case series of coronary angioplasty in patients with right-sided heart.
    Catheter Cardiovasc Interv. 2024 Feb 12. doi: 10.1002/ccd.30973.
    >> Share

  49. VAN BAKEL PAJ, Ahmed Y, Hou H, Sukul D, et al
    Geographic variation in aortic stenosis treatment and outcomes among Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2024 Feb 8. doi: 10.1002/ccd.30959.
    >> Share

  50. SPIRITO A, Cohen R, Sartori S, Vogel B, et al
    Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 5. doi: 10.1002/ccd.30960.
    >> Share

  51. JOLLEY MA, Sulentic A, Amin S, Gupta M, et al
    Introduction of transcatheter edge-to-edge repair in patients with congenital heart disease at a children's hospital.
    Catheter Cardiovasc Interv. 2024;103:326-334.
    >> Share

  52. SUZUKA Y, Hirano K, Tokuda T, Diaz JP, et al
    JETWING technique: Combination therapy of JETSTREAM(?) and aggressive wire recanalization in calcified atheroma and dilatation technique for eccentric heavy calcified plaques using WINGMAN for insertion of protection wire.
    Catheter Cardiovasc Interv. 2024;103:335-339.
    >> Share

  53. RIVERO-SANTANA B, Jimenez-Valero S, Jurado-Roman A, Galeote G, et al
    The BALTO Registry: Long-term results of percutaneous BALloon pericardioTomy in oncological patients.
    Catheter Cardiovasc Interv. 2024;103:482-489.
    >> Share

  54. BOSCAMP NS, Maschietto N, Porras D
    Transcatheter pulmonary valve replacement in surgically-created double-barrel right ventricular outflow tracts: A single center case-series.
    Catheter Cardiovasc Interv. 2024;103:455-463.
    >> Share

    January 2024
  55. VOLET C, Puricel S, Cook ST, di Cicco P, et al
    Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30961.
    >> Share

  56. CHICHAREON P, Chamnarnphol N, Chandavimol M, Suwannasom P, et al
    Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2024 Jan 14. doi: 10.1002/ccd.30940.
    >> Share

  57. JONES D, Spirito A, Sartori S, Vogel B, et al
    Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30939.
    >> Share

  58. KAWAMURA A, Egami Y, Okamoto N, Kawanami S, et al
    Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model.
    Catheter Cardiovasc Interv. 2024;103:42-50.
    >> Share

  59. SHEKILADZE N, Sandesara PB, Tai Z, Maisuradze N, et al
    Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series.
    Catheter Cardiovasc Interv. 2024;103:89-96.
    >> Share

  60. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    >> Share

  61. HEATON J, Imburgio S, Dandu S, Johal A, et al
    Geographic variability and operator trends of transcatheter edge-to-edge repair in the United States.
    Catheter Cardiovasc Interv. 2024;103:147-152.
    >> Share

  62. JIN P, Wang Y, Liu Y, Yang J, et al
    Transapical concomitant transseptal transcatheter closure of a giant mitral paravalvular leak under three-dimensional printing guidance.
    Catheter Cardiovasc Interv. 2024;103:243-247.
    >> Share

    December 2023
  63. SAITO T, Kuno T, Ueyama HA, Kampaktsis PN, et al
    Transcatheter edge-to-edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Dec 29. doi: 10.1002/ccd.30944.
    >> Share

  64. DEMIRCI G, Aslan S, Guner A, Demir AR, et al
    Clinical implication of the Naples prognostic score on transcatheter aortic valve replacement in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30929.
    >> Share

  65. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    >> Share

  66. FISCHER J, Steffen J, Arlart T, Haum M, et al
    Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30927.
    >> Share

  67. AROW Z, Konigstein M, Vaknin-Assa H, Witberg G, et al
    Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Dec 14. doi: 10.1002/ccd.30924.
    >> Share

  68. NOORI M, Christiansen EH, Raungaard B, Junker A, et al
    Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Dec 13. doi: 10.1002/ccd.30937.
    >> Share

  69. YANG Y, Chen J, Dong L, Lu Y, et al
    Transcatheter mitral valve replacement with Mi-thos system: First-in-human experience.
    Catheter Cardiovasc Interv. 2023 Dec 9. doi: 10.1002/ccd.30926.
    >> Share

  70. BARBASH IM, Wasserstrum Y, Erlebach M, Guetta V, et al
    Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 7. doi: 10.1002/ccd.30921.
    >> Share

  71. JIN Q, Long Y, Zhang G, Pan X, et al
    Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2023 Dec 6. doi: 10.1002/ccd.30916.
    >> Share

  72. PIEDIMONTE G, Azzalini L, Ferrarotto L, Mangione R, et al
    Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry.
    Catheter Cardiovasc Interv. 2023 Dec 4. doi: 10.1002/ccd.30928.
    >> Share

  73. BASAVARAJAIAH S, Kalkat H, Bhatia G, Cortese B, et al
    How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
    Catheter Cardiovasc Interv. 2023;102:1238-1257.
    >> Share

  74. MOVAHED MR
    Movahed coronary bifurcation classification should be the preferred classification for studying true bifurcation lesions as it summarizes true bifurcation lesions in only one simple category called B2 Lesion with limitless optional suffixes.
    Catheter Cardiovasc Interv. 2023;102:1263-1264.
    >> Share

  75. ORZALKIEWICZ M, Bruno AG, Saia F, Palmerini T, et al
    A novel high-risk aortic root anatomy for right coronary artery occlusion during TAVI.
    Catheter Cardiovasc Interv. 2023;102:1389-1392.
    >> Share

  76. PELLEGRINI C, Freissmuth M, Rheude T, Graas D, et al
    Implantation depth of balloon-expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events.
    Catheter Cardiovasc Interv. 2023;102:1301-1310.
    >> Share

  77. CURIO J, Khokhar AA, Beneduce A, Mylotte D, et al
    Patient-specific commissural alignment for ACURATE neo2 implantation in degenerated surgical bioprostheses.
    Catheter Cardiovasc Interv. 2023;102:1401-1405.
    >> Share

    November 2023
  78. SCHNEEBERGER Y, Sarwari H, Koll B, Demal TJ, et al
    Balloon-expandable transcatheter heart valves for treatment of aortic valve stenosis in patients with large aortic annuli: Evaluation of deployment balloon overfilling strategies.
    Catheter Cardiovasc Interv. 2023 Nov 30. doi: 10.1002/ccd.30922.
    >> Share

  79. ALJABBARY TF, Komatsu I, Ochiai T, Fremes SE, et al
    Cusp overlap method for self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Nov 27. doi: 10.1002/ccd.30910.
    >> Share

  80. JAVAID AI, Michalek JE, Gruslova AB, Hoskins SA, et al
    Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Nov 23. doi: 10.1002/ccd.30913.
    >> Share

  81. ANDROSHCHUK V, Chehab O, Prendergast B, Rajani R, et al
    Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review.
    Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30918.
    >> Share

  82. SIMSEK B, Rempakos A, Kostantinis S, Alexandrou M, et al
    International survey of chronic total occlusion percutaneous coronary intervention operators.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30914.
    >> Share

  83. SHARMA S, Nakamura M
    Percutaneous treatment of mechanical mitral valve thrombosis.
    Catheter Cardiovasc Interv. 2023 Nov 16. doi: 10.1002/ccd.30900.
    >> Share

  84. SANZ SANCHEZ J, Regazzoli D, Barbanti M, Fiorina C, et al
    Impact of balloon post-dilation on valve durability and long-term clinical outcomes after self-expanding transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Nov 13. doi: 10.1002/ccd.30907.
    >> Share

  85. MAJEED H, Blankenship JC
    Ellis type 4 coronary artery perforation during percutaneous coronary intervention: Case series and review.
    Catheter Cardiovasc Interv. 2023 Nov 10. doi: 10.1002/ccd.30873.
    >> Share

  86. NUMASAWA Y, Sawano M, Ishii H, Kohsaka S, et al
    One-year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J-PCI OUTCOME registry.
    Catheter Cardiovasc Interv. 2023 Nov 9. doi: 10.1002/ccd.30895.
    >> Share

  87. LIU X, Zhang Y, Xu Y, Tang Z, et al
    Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30909.
    >> Share

  88. COZZI O, Maurina M, Cacia M, Bernardini V, et al
    Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
    Catheter Cardiovasc Interv. 2023 Nov 7. doi: 10.1002/ccd.30903.
    >> Share

  89. ALADIN AI, Wermers JP, Zhang C, Case BC, et al
    Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Nov 5. doi: 10.1002/ccd.30896.
    >> Share

  90. MCCABE JM, Helmy T
    Balloon-assisted leaflet modification: Gaining momentum with innovative approaches.
    Catheter Cardiovasc Interv. 2023;102:962-963.
    >> Share

  91. ZAHR F, Lantz G
    Bi-cuspid TAVR; bye or buy!
    Catheter Cardiovasc Interv. 2023;102:960-961.
    >> Share

  92. WILLEMEN Y, De Backer O
    Stroke prevention in TAVR: A patient-tailored approach may be needed.
    Catheter Cardiovasc Interv. 2023;102:964-965.
    >> Share

  93. RISSANEN TT, Kleber FX, Scheller B
    Drug-coated balloon angioplasty is a well-established treatment and in everyday use in cathlabs worldwide.
    Catheter Cardiovasc Interv. 2023;102:912-913.
    >> Share

  94. RESTIVO A, Stanzione A, Maffeo D, Buono A, et al
    Ping-pong snaring of a totally dislodged stent across left main ostium: "All is not lost".
    Catheter Cardiovasc Interv. 2023;102:889-891.
    >> Share

  95. TAN BE, Hashem A, Boppana LKT, Mohamed MS, et al
    Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2023;102:919-928.
    >> Share

  96. HERRMANN HC
    Hemodynamics after TAVR matter.
    Catheter Cardiovasc Interv. 2023;102:944-945.
    >> Share

  97. LEONE PP, Regazzoli D, Pagnesi M, Costa G, et al
    Prosthesis-patient mismatch after transcatheter implantation of contemporary balloon-expandable and self-expandable valves in small aortic annuli.
    Catheter Cardiovasc Interv. 2023;102:931-943.
    >> Share

  98. BLACHUTZIK F, Meier S, Weissner M, Schlattner S, et al
    Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.
    Catheter Cardiovasc Interv. 2023;102:823-833.
    >> Share

  99. EL KHOURY A, Lazar L, Cortese B
    The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    Catheter Cardiovasc Interv. 2023;102:979-986.
    >> Share

  100. SANDESARA PB, Elhage Hassan M, Shekiladze N, Turk AA, et al
    Intravascular lithotripsy compared to rotational atherectomy for the treatment of calcified distal left main coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2023;102:997-1003.
    >> Share

  101. UEDA H, Fujiwara Y, Nishida Y, Maenaka M, et al
    Impact of prolonged drug-coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis.
    Catheter Cardiovasc Interv. 2023;102:969-978.
    >> Share

  102. GORLA R, Tua L, D'Errigo P, Barbanti M, et al
    Incidence and predictors of 30-day and 6-month stroke after TAVR: Insights from the multicenter OBSERVANT II study.
    Catheter Cardiovasc Interv. 2023;102:1122-1131.
    >> Share

  103. CRITCHFIELD DR, Chamberlain RC, Turek JW, Fleming GA, et al
    Hybrid approach to pulmonary vein stenting after Fontan palliation.
    Catheter Cardiovasc Interv. 2023;102:1095-1100.
    >> Share

  104. STEINBERG ZL, Cabalka AK, Balzer DT, Asnes JD, et al
    Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: Potential mechanisms and treatment.
    Catheter Cardiovasc Interv. 2023;102:1078-1087.
    >> Share

  105. MERINOPOULOS I, Gunawardena T, Corballis N, Tsampasian V, et al
    Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:987-996.
    >> Share

    October 2023
  106. SHIMAMURA J, Takemoto S, Fukuhara S, Miyamoto Y, et al
    Long-term outcomes after transcatheter aortic valve replacement: Meta-analysis of Kaplan-Meier-derived data.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30854.
    >> Share

  107. SAVVOULIDIS P, Nadir AM, Mechery A, Lawton E, et al
    Routine postaccess-closure angiography to detect vascular complications following transfemoral TAVR.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30894.
    >> Share

  108. GEISLER T, Schreieck J, Euper M, Zdanyte M, et al
    Outcomes of patients undergoing edge-to-edge mitral valve repair with the Edwards PASCAL transcatheter valve repair system under conscious sedation.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30866.
    >> Share

  109. WONG N, Fowler D, Lim DS
    Mitral valve-in-valve with 4D intracardiac echocardiography: Procedural and imaging technique.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30897.
    >> Share

  110. MOHAMED MO, Kinnaird T, Rab ST, Zaman S, et al
    Intracoronary imaging guided percutaneous coronary intervention outcomes among individuals with cardiogenic shock.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30859.
    >> Share

  111. VELAGAPUDI P, Turagam MK
    Utility of rapid atrial pacing before and after transcatheter aortic valve replacement to predict permanent pacemaker implantation: A valuable piece of the puzzle?
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30880.
    >> Share

  112. LU H, Hu Y, Ma Y, Zhou Y, et al
    Exploring indicators of success in chronic total occlusion percutaneous coronary intervention with Stingray system-based antegrade dissection re-entry: Insights from retrospective analysis.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30889.
    >> Share

  113. CORTESE B, Kalkat H, Bathia G, Basavarajaiah S, et al
    The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30891.
    >> Share

  114. MAGYARI B, Kittka B, Gojak I, Kasza G, et al
    Single center experience with the balloon-expandable Myval transcatheter aortic valve system with the first 100 patients: 30-day and 1-year follow-up.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30868.
    >> Share

  115. LORIA JRD, Abdelhafez A, Desch S, Thiele H, et al
    Transcatheter aortic valve implantation in patients with anomalous origin of a coronary artery.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30860.
    >> Share

  116. NILSSON K, Buccheri S, Lindback J, Sarno G, et al
    External validation of the Netherlands Heart Registration (NHR) prediction model for early mortality after transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30887.
    >> Share

  117. SKALIDIS I, Hamilos M, Petousis S, Kochiadakis G, et al
    Successful closure of transcatheter aortic valve replacement-induced Gerbode defect with valve-in-valve technique: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30882.
    >> Share

  118. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    >> Share

  119. MAURINA M, Chiarito M, Leone PP, Testa L, et al
    Randomized clinical trial of abluminus DES+ sirolimus-eluting stent versus everolimus-eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30853.
    >> Share

  120. WONG N, Lim DS, Yount K, Yarboro L, et al
    Preemptive alcohol septal ablation prior to transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30879.
    >> Share

  121. AL MAWED M, Vlachojannis M, Pula A, Gielen S, et al
    Delayed coronary perforation four days after percutaneous coronary intervention with subsequent cardiac tamponade: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30861.
    >> Share

  122. SPILIAS N, Miyasaka R, Kapadia SR, Krishnaswamy A, et al
    A novel method of prosthetic leaflet modification to enable transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30872.
    >> Share

  123. KLEBER FX
    Commentary: Dissection still a sticking point in the widespread use of DCB in PCI.
    Catheter Cardiovasc Interv. 2023;102:772-773.
    >> Share

    September 2023
  124. SHAMKHANI W, Moledina S, Rashid M, Mamas MA, et al
    Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.
    Catheter Cardiovasc Interv. 2023 Sep 26. doi: 10.1002/ccd.30846.
    >> Share

  125. BARRETT CD, Nickel A, Rosenberg MA, Ream K, et al
    PRIME score for prediction of permanent pacemaker implantation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 21. doi: 10.1002/ccd.30845.
    >> Share

  126. SOUD M, Feit F, Rao S, Bangalore S, et al
    Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30844.
    >> Share

  127. ROTH N, Heidel C, Xu C, Hubauer U, et al
    Restoration of von Willebrand factor after transcatheter aortic valve replacement-A possible cause for posttranscatheter aortic valve replacement thrombocytopenia?
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30841.
    >> Share

  128. DI MAIO M, Esposito L, Silverio A, Bellino M, et al
    Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
    >> Share

  129. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    >> Share

  130. HOLZAMER A, Bedogni F, van Wyk P, Barwad P, et al
    Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real-world scenario: First global, multicenter experience.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30820.
    >> Share

  131. AHN J, Yu H, Rha SW, Choi BG, et al
    Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
    >> Share

  132. REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
    Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
    >> Share

  133. HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
    Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
    >> Share

  134. ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
    Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
    >> Share

  135. SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
    Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
    Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
    >> Share

  136. BRUNO F, Kang J, Elia E, Han JK, et al
    Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
    >> Share

  137. FIORINA C, Massussi M, Ancona M, Montorfano M, et al
    Mid-term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30813.
    >> Share

  138. HOKKEN TW, Wienemann H, Dargan J, Ginkel DV, et al
    Clinical value of CT-derived simulations of transcatheter-aortic-valve-implantation in challenging anatomies the PRECISE-TAVI trial.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30816.
    >> Share

  139. TRIANTAFYLLIS AS, Desmet W, Tonino PAL
    Diagnosing aberrant circumflex artery prior to transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30819.
    >> Share

  140. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    >> Share

    August 2023
  141. KUNA C, Wiedenmayer N, Bradaric C, Presch A, et al
    Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30807.
    >> Share

  142. GUPTA R, Mahmoudi E, Behnoush AH, Malik AH, et al
    Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30808.
    >> Share

  143. HAMADA S, Ueyama H, Aikawa T, Kampaktsis PN, et al
    Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Aug 14. doi: 10.1002/ccd.30806.
    >> Share

  144. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
    Catheter Cardiovasc Interv. 2023 Aug 10. doi: 10.1002/ccd.30798.
    >> Share

  145. SUZUKI N
    Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
    Catheter Cardiovasc Interv. 2023;102:392-393.
    >> Share

  146. ZAHR F, Chadderdon S
    Long-term results of M-TEER: A mountain of data with gaps to cross.
    Catheter Cardiovasc Interv. 2023;102:400-401.
    >> Share

  147. LONG Y, Li W, Chen S, Li M, et al
    Novel arm-width-expandable transcatheter edge-to-edge repair system: Preclinical experiment and first-in-human study.
    Catheter Cardiovasc Interv. 2023;102:301-309.
    >> Share

    July 2023
  148. GROGER M, Zeiml KP, Schneider LM, Rottbauer W, et al
    Impact of concomitant tricuspid regurgitation on outcome after edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2023 Jul 28. doi: 10.1002/ccd.30787.
    >> Share

  149. ZHENG HJ, Yan CJ, Lin DQ, Cheng YB, et al
    Prognostic impact of new permanent pacemaker implantation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30788.
    >> Share

  150. KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
    Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
    >> Share

  151. ELBADAWI A, Dang AT, Hamed M, Ali A, et al
    Transcatheter edge-to-edge repair for mitral regurgitation using PASCAL or MitraClip.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30772.
    >> Share

  152. GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
    Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
    >> Share

  153. PARK DY, An S, Jolly N, Attanasio S, et al
    Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
    >> Share

  154. AIJAZ B, Glorioso TJ, Butala N, Waldo SW, et al
    Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30782.
    >> Share

  155. SONODA S, Node K
    Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
    >> Share

  156. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    >> Share

  157. GHIZZONI G, Ancona MB, Romano V, Bellini B, et al
    Mind the "commissural drop" when crossing the aortic valve!
    Catheter Cardiovasc Interv. 2023 Jul 18. doi: 10.1002/ccd.30763.
    >> Share

  158. NATALIS A, Masson JB, Mansour MJ, Asmar MA, et al
    Correlation between measured and predicted mismatch with valve hemodynamics in transcatheter aortic valve replacement: A sex-based analysis.
    Catheter Cardiovasc Interv. 2023 Jul 14. doi: 10.1002/ccd.30764.
    >> Share

  159. ZAMORANO JL, Appleby C, Benamer H, Frankenstein L, et al
    Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement.
    Catheter Cardiovasc Interv. 2023 Jul 11. doi: 10.1002/ccd.30760.
    >> Share

  160. FAROUK H, Schone D, Witt C, Bayyud H, et al
    Papillary muscle rupture after transcatheter aortic valve implantation: A case report and literature review.
    Catheter Cardiovasc Interv. 2023 Jul 7. doi: 10.1002/ccd.30761.
    >> Share

  161. LANG FM, Mihatov N, Kriegel J, Nazif TM, et al
    Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience.
    Catheter Cardiovasc Interv. 2023 Jul 2. doi: 10.1002/ccd.30755.
    >> Share

  162. MITSUI K, Lee T, Miyazaki R, Hara N, et al
    Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Catheter Cardiovasc Interv. 2023;102:11-17.
    >> Share

    June 2023
  163. BLANKE P, Modine T, Duncan A, Taramasso M, et al
    Anatomic suitability for transapical transcatheter mitral valve implantation using a tether-based device.
    Catheter Cardiovasc Interv. 2023 Jun 24. doi: 10.1002/ccd.30752.
    >> Share

  164. REZKALLA J, Reddy Y, Nishimura RA, Padang R, et al
    Right heart catheterization predictors of symptomatic improvement in patients undergoing transcatheter tricuspid valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30754.
    >> Share

  165. YOKOYAMA H, Ochiai T, Saito S
    Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review.
    Catheter Cardiovasc Interv. 2023 Jun 21. doi: 10.1002/ccd.30751.
    >> Share

  166. PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
    Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
    >> Share

  167. LOPEZ-MINGUEZ JR, Martin de Francisco AL, Soler MJ, Hernandez F, et al
    Cost-effectiveness analysis of dyevert Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain.
    Catheter Cardiovasc Interv. 2023 Jun 10. doi: 10.1002/ccd.30744.
    >> Share

  168. AURIGEMMA C, Trani C, D'Errigo P, Barbanti M, et al
    Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study.
    Catheter Cardiovasc Interv. 2023 Jun 2. doi: 10.1002/ccd.30695.
    >> Share

  169. DE LA TORRE HERNANDEZ JM, Veiga Fernandez G, Barrera S, Sainz Laso F, et al
    Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation.
    Catheter Cardiovasc Interv. 2023;101:1214-1220.
    >> Share

  170. PERSHAD A
    CTO revascularization in TAVR patients-The jury is still out.
    Catheter Cardiovasc Interv. 2023;101:1229.
    >> Share

  171. MERDLER I, Bernardo NL, Ben-Dor I, Waksman R, et al
    Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series.
    Catheter Cardiovasc Interv. 2023;101:1235-1238.
    >> Share

    May 2023
  172. WOLFRUM M, Moccetti F, Loretz L, Bossard M, et al
    Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30697.
    >> Share

  173. DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
    Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
    >> Share

  174. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30698.
    >> Share

  175. RJOOB K, McGilligan V, McAllister R, Bond R, et al
    What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
    >> Share

  176. HO CB, Vejlstrup NG, De Backer O, Sondergaard L, et al
    Intracardiac echocardiogram to diagnose infective endocarditis after transcatheter aortic valve-in-valve implantation.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30694.
    >> Share

  177. OKSNES A, Skaar E, Engan B, Bleie O, et al
    Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
    Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
    >> Share

  178. SPARGIAS K, Lim DS, Makkar R, Kar S, et al
    Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.
    Catheter Cardiovasc Interv. 2023 May 13. doi: 10.1002/ccd.30686.
    >> Share

  179. DING D, Tu S, Li Y, Li C, et al
    Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
    >> Share

  180. GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
    Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
    >> Share

  181. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
    >> Share

  182. HAMEED I, Ahmed A, Kumar A, Li E, et al
    Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30674.
    >> Share

  183. ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
    Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
    >> Share

  184. CALI F, Pagnesi M, Pezzola E, Montisci A, et al
    Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30682.
    >> Share

  185. CADER A, Alasnag M
    Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
    >> Share

  186. BUCKLEY AJ, Hensey M, O'Connor S, Maree A, et al
    Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices.
    Catheter Cardiovasc Interv. 2023 May 7. doi: 10.1002/ccd.30675.
    >> Share

  187. MUSTAFA U, Helmy T
    TAVR for all-Is it time?
    Catheter Cardiovasc Interv. 2023;101:1174-1175.
    >> Share

  188. FELDMAN D, Cao D, Sartori S, Zhang Z, et al
    Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2023;101:1134-1143.
    >> Share

  189. SAMIMI S, Chavez Ponce A, Alarouri HS, Shaer AE, et al
    Predictors of hemodynamic response to mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023;101:1120-1127.
    >> Share

  190. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    >> Share

  191. YIN J, Wang R, Chen H, Lu H, et al
    In vivo evaluation of intravascular lithotripsy in a healthy porcine coronary model.
    Catheter Cardiovasc Interv. 2023;101:1062-1070.
    >> Share

  192. SETO AH
    Cut, score, press, shock, or ablate?
    Catheter Cardiovasc Interv. 2023;101:975-977.
    >> Share

    April 2023
  193. YESANTHARAO PS, Etchill EW, Zhou AL, Ong CS, et al
    The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.
    Catheter Cardiovasc Interv. 2023 Apr 27. doi: 10.1002/ccd.30670.
    >> Share

  194. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Apr 18. doi: 10.1002/ccd.30666.
    >> Share

  195. HOSSEINI M, Lahr BD, Greason KL, Arghami A, et al
    Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2023 Apr 10. doi: 10.1002/ccd.30658.
    >> Share

  196. HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
    Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
    Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
    >> Share

  197. GRINES CL, Tummala PE
    Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
    Catheter Cardiovasc Interv. 2023;101:959-960.
    >> Share

  198. HADDAD RN, Dautry R, Bonnet D, Malekzadeh-Milani S, et al
    Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.
    Catheter Cardiovasc Interv. 2023;101:863-869.
    >> Share

    March 2023
  199. TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
    Measures of social deprivation and outcomes after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
    >> Share

  200. MEIJERINK F, Holierook M, Eberl S, Robbers-Visser D, et al
    Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitation.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30645.
    >> Share

  201. SIMSEK B, Khatri J, Young L, Kostantinis S, et al
    Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
    >> Share

  202. MORI H, Kurita T, Takasaki A, Dohi K, et al
    Plaque characterization of a saphenous vein graft by near-infrared spectroscopy and histopathology in a patient with a percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30641.
    >> Share

  203. HILLEGASS WB
    Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30640.
    >> Share

  204. RYAN N, Alasnag M
    Commentary on "Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry".
    Catheter Cardiovasc Interv. 2023 Mar 21. doi: 10.1002/ccd.30643.
    >> Share

  205. ALLANA SS, Brilakis ES
    What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
    >> Share

  206. ALI N, Hildick-Smith D, Parker J, Malkin CJ, et al
    Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30627.
    >> Share

  207. AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
    Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
    >> Share

  208. POSTALIAN A, Krajcer Z
    The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
    >> Share

  209. LEE A, Gilchrist IC
    A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
    Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
    >> Share

  210. UEYAMA H, Block PC
    Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?
    Catheter Cardiovasc Interv. 2023;101:830-831.
    >> Share

  211. HEUSER RR
    Regulators can we get DCB balloons approved for use in the United States?
    Catheter Cardiovasc Interv. 2023;101:834-835.
    >> Share

  212. MANGIERI A, Nerla R, Castriota F, Reimers B, et al
    Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
    Catheter Cardiovasc Interv. 2023;101:798-805.
    >> Share

    February 2023
  213. UENO K, Morita N, Kojima Y, Takahashi H, et al
    Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
    >> Share

  214. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
    >> Share

  215. HEATON J, Singh S, Nanavaty D, Okoh AK, et al
    Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
    >> Share

  216. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    >> Share

  217. SEDHOM R, Dang AT, Elwagdy A, Megaly M, et al
    Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30597.
    >> Share

  218. REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
    Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
    >> Share

  219. KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
    Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
    >> Share

  220. NATANZON SS, Koseki K, Kaewkes D, Koren O, et al
    Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge-to-edge repair patients.
    Catheter Cardiovasc Interv. 2023;101:596-604.
    >> Share

  221. ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
    Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
    Catheter Cardiovasc Interv. 2023;101:553-562.
    >> Share

  222. ERDEM S, An SY, McAlister CA, Basra SS, et al
    Suicide left ventricle following protamine: A case report.
    Catheter Cardiovasc Interv. 2023;101:592-595.
    >> Share

    January 2023
  223. LUGO-FAGUNDO N, Pierre K, Adedinsewo D, Simard T, et al
    The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jan 30. doi: 10.1002/ccd.30577.
    >> Share

  224. ALVAREZ-COVARRUBIAS HA, Joner M, Cassese S, Warmbrunn M, et al
    Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease.
    Catheter Cardiovasc Interv. 2023 Jan 29. doi: 10.1002/ccd.30576.
    >> Share

  225. HIRUMA T, Higuchi R, Saji M, Takamisawa I, et al
    Transcatheter aortic valve replacement-related aortic dissection: A clinical case series.
    Catheter Cardiovasc Interv. 2023 Jan 26. doi: 10.1002/ccd.30574.
    >> Share

  226. KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
    Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
    >> Share

  227. KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
    Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
    >> Share

  228. CHEN H, Spirito A, Sartori S, Nicolas J, et al
    Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
    >> Share

  229. RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
    >> Share

  230. AZZALINI L, Boudou N, Avran A, Kane J, et al
    Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
    >> Share

  231. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: A meta-analysis of comparative studies.
    Catheter Cardiovasc Interv. 2023 Jan 19. doi: 10.1002/ccd.30562.
    >> Share

  232. MONTARELLO NJ, Quagliana A, Sondergaard L, De Backer O, et al
    Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2023 Jan 18. doi: 10.1002/ccd.30561.
    >> Share

  233. SAVVOULIDIS P, Nadir AM, Mechery A, Doshi SN, et al
    A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jan 14. doi: 10.1002/ccd.30557.
    >> Share

  234. ISMAYL M, Machanahalli Balakrishna A, Elgayesh MM, Thandra A, et al
    Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30549.
    >> Share

  235. CHEN J, Yang Y, Song W, Feng D, et al
    Transcatheter tricuspid valve-in-valve implantation for degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30554.
    >> Share

  236. DAVIS MG, Blankenship JC
    PCI for late STEMI: Better late than never?
    Catheter Cardiovasc Interv. 2023;101:11-12.
    >> Share

  237. DOOST A, Chilmeran A, Gomes A, Dworakowski R, et al
    Single arterial access closure of post-infarction ventricular septal defect: A case series.
    Catheter Cardiovasc Interv. 2023;101:209-216.
    >> Share

  238. SHIBBANI K, Aboulhosn J, Levi D, Mohammad Nijres B, et al
    Hybrid approach for harmony transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2023;101:135-139.
    >> Share

  239. BINGEN BO, Al Amri I, Montero-Cabezas JM, van der Kley F, et al
    Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction.
    Catheter Cardiovasc Interv. 2023;101:97-101.
    >> Share

    December 2022
  240. BARBOSA MOREIRA MJ, Peixoto NADA, Udoma-Udofa OC, de Araujo SLS, et al
    Direct oral anticoagulant versus antiplatelet therapy following transcatheter aortic valve replacement in patients without prior or concurrent indication for anticoagulation: A meta-analysis of randomized studies.
    Catheter Cardiovasc Interv. 2022 Dec 27. doi: 10.1002/ccd.30532.
    >> Share

  241. ISOGAI T, Agrawal A, Shekhar S, Spilias N, et al
    One-year clinical and echocardiographic outcomes of transcatheter aortic valve replacement with SAPIEN 3 Ultra versus SAPIEN 3.
    Catheter Cardiovasc Interv. 2022 Dec 13. doi: 10.1002/ccd.30515.
    >> Share

  242. ROUT A, Sharma A, Ikram S, Garg A, et al
    Short-term dual antiplatelet therapy for 1-3 months after percutaneous coronary intervention using drug eluting stents: A systematic review and meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2022 Dec 9. doi: 10.1002/ccd.30521.
    >> Share

  243. QIAN J, Wu Y, Li C, Yin J, et al
    Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
    Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
    >> Share

  244. ZAID S, Haniyeh AA, Rosenzveig A, Malik A, et al
    Minimalist transcatheter aortic valve replacement misses paravalvular regurgitation: Incidence and echocardiographic distribution of missed paravalvular regurgitation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30512.
    >> Share

  245. OGAMI T, Kliner DE, Toma C, Serna-Gallegos D, et al
    Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30508.
    >> Share

  246. EL HAJJ M, Krajcer Z
    Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?
    Catheter Cardiovasc Interv. 2022;100:1300-1301.
    >> Share

  247. MICHAIL M, Cockburn J, Tanseco KVP, Arunothayaraj S, et al
    Feasibility of transcaval access TAVI in morbidly obese patients: A single-center experience.
    Catheter Cardiovasc Interv. 2022;100:1302-1306.
    >> Share

  248. TOMII D, Okuno T, Lanz J, Stortecky S, et al
    Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 1. doi: 10.1002/ccd.30507.
    >> Share

    November 2022
  249. TANNER R, Murphy S, Malone C, McGorrian C, et al
    Correlation of aortic valve annular plane assessment by on-table three-dimensional rotational angiography and preprocedural computed tomography.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30469.
    >> Share

  250. NG JCK, Ang H, Zhong L, Hakim D, et al
    Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
    >> Share

  251. AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
    Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
    >> Share

  252. SAMMOUR YM, Lak H, Chahine J, Abushouk A, et al
    Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30488.
    >> Share

  253. BALDUS S, Schofer N, Hausleiter J, Friedrichs K, et al
    Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30450.
    >> Share

  254. NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
    Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
    >> Share

  255. SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
    Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
    >> Share

  256. LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
    Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
    >> Share

  257. MEREDITH T, Scheuer S, Hoffman M, Joshi Y, et al
    Coronary angiography of the ex-situ beating donor heart in a portable organ care system.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30455.
    >> Share

  258. MILLER MS, Cutts J, Donatelle M, Shah K, et al
    Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30471.
    >> Share

  259. ABDULLA A, Jneid H
    Transcatheter therapies for severe aortic and mitral stenosis: To stage or not to stage?
    Catheter Cardiovasc Interv. 2022;100:901-902.
    >> Share

  260. ALLANA SS, Brilakis ES
    How good is intravascular brachytherapy for treating in-stent restenosis?
    Catheter Cardiovasc Interv. 2022;100:763-764.
    >> Share

  261. NARAYANAN A, Jneid H
    A new frontier in left atrial appendage closure.
    Catheter Cardiovasc Interv. 2022;100:929-930.
    >> Share

  262. UEYAMA H, Block PC
    Membranous septum length may not be the answer.
    Catheter Cardiovasc Interv. 2022;100:877-878.
    >> Share

  263. JONES EL, Blankenship JC
    Women deserve the best care.
    Catheter Cardiovasc Interv. 2022;100:936-937.
    >> Share

  264. SATLER LF
    When possible, try to avoid emergent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;100:839-840.
    >> Share

  265. TAYLOR A, Yang J, Dubin A, Chubb MH, et al
    Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device.
    Catheter Cardiovasc Interv. 2022;100:766-773.
    >> Share

  266. CHAVARRIA J, Falcao F, Dutra G, Sathananthan J, et al
    Bespoke valve sizing avoids annular rupture in patients treated with a balloon-expandable transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;100:823-831.
    >> Share

  267. SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
    Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;100:749-755.
    >> Share

  268. CHAMI T, Mahowald MK, Brilakis E
    Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
    Catheter Cardiovasc Interv. 2022;100:756-758.
    >> Share

  269. SHAMEKHI J, Hasse C, Veulemans V, Al-Kassou B, et al
    A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR-A multicenter analysis.
    Catheter Cardiovasc Interv. 2022;100:850-859.
    >> Share

  270. WINSCOTT JG, Hillegass WB
    Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
    Catheter Cardiovasc Interv. 2022;100:747-748.
    >> Share

  271. UEYAMA H, Block PC
    Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?
    Catheter Cardiovasc Interv. 2022;100:1132-1133.
    >> Share

  272. SALAETS T, Cools B, De Meester P, Heying R, et al
    Stent expansion of restrictive Fontan conduits to nominal diameter and beyond.
    Catheter Cardiovasc Interv. 2022;100:1059-1066.
    >> Share

  273. NAGASAKA T, Amanai S, Ishibashi Y, Aihara K, et al
    Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;100:971-978.
    >> Share

  274. ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
    Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
    Catheter Cardiovasc Interv. 2022;100:979-989.
    >> Share

  275. PICCOLO R, Esposito G
    Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100:1146-1147.
    >> Share

  276. SETH A, Ezhumalai B
    Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
    Catheter Cardiovasc Interv. 2022;100:1148-1149.
    >> Share

  277. ALLANA SS, Brilakis ES
    Why complex and high risk percutaneous coronary interventions should be offered to selected octogenarians/nonagenarians.
    Catheter Cardiovasc Interv. 2022;100:1143-1145.
    >> Share

  278. BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
    Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
    >> Share

  279. SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
    The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
    >> Share

  280. KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
    Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
    >> Share

    October 2022
  281. NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
    Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
    Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
    >> Share

  282. KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
    Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
    >> Share

  283. TEBAR MARQUEZ D, Moreno R, Galeote G, Jurado-Roman A, et al
    Transcatheter aortic valve with a novel self-expandable device in patients with previous mechanical mitral valve prosthesis.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30449.
    >> Share

  284. GERCEK M, Irimie AA, Gercek M, Fox H, et al
    Cognitive function in late-stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30443.
    >> Share

  285. YASHIGE M, Zen K, Takamatsu K, Matoba S, et al
    Additional balloon aortic valvuloplasty to overcome the difficult removal of a self-expandable transcatheter aortic valve system due to valve infolding.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30444.
    >> Share

  286. SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
    Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
    >> Share

  287. VERREAULT-JULIEN L, Shekiladze N, Wollmuth J, Rinfret S, et al
    Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide.
    Catheter Cardiovasc Interv. 2022 Oct 13. doi: 10.1002/ccd.30427.
    >> Share


  288. Erratum to "Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience".
    Catheter Cardiovasc Interv. 2022 Oct 4. doi: 10.1002/ccd.30409.
    >> Share

  289. MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
    Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
    >> Share

  290. EARLE W, Abdallah G, Meagher S, Shen K, et al
    Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30412.
    >> Share

  291. ULLAH W, Zahid S, Muhammadzai H, Khalil F, et al
    Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30407.
    >> Share

  292. KHOKHAR AA, Giannini F, Zlahoda-Huzior A, Mikhail G, et al
    Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: Insights from ex vivo simulations.
    Catheter Cardiovasc Interv. 2022;100:662-666.
    >> Share

  293. ZABLAH JE, Dohlen G, Ystgaard MB, Morgan GJ, et al
    Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2022;100:606-611.
    >> Share

  294. CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
    Orbital atherectomy of calcified coronary ostial lesions.
    Catheter Cardiovasc Interv. 2022;100:553-559.
    >> Share

    September 2022
  295. MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
    Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
    >> Share

  296. BASHAR H, Matetic A, Curzen N, Mamas MA, et al
    Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
    >> Share

  297. BERKOVITCH A, Segev A, Guetta V, Finkelstein A, et al
    Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30386.
    >> Share

  298. ABUSHOUK AI, Abdelfattah O, Gad MM, Saad A, et al
    Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30388.
    >> Share

  299. CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
    Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
    Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
    >> Share

  300. ZAHR F, Chadderdon S, Song H, Sako E, et al
    Contemporary diagnosis and management of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2022 Sep 10. doi: 10.1002/ccd.30364.
    >> Share

  301. HIOKI H, Watanabe Y, Kozuma K, Ryuzaki T, et al
    Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30377.
    >> Share

  302. AL-FARRA H, Ravelli ACJ, Henriques JPS, Houterman S, et al
    Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI-NHR risk model.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30398.
    >> Share

  303. SHAMKHANI W, Rashid M, Mamas M
    Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
    Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
    >> Share

  304. GRINES CL, Dupont A
    Turndown for coronary artery bypass surgery: Never say never to revascularization.
    Catheter Cardiovasc Interv. 2022;100:367-368.
    >> Share

  305. TARANTINI G, Cardaioli F
    SAPIEN 3 transcatheter heart valve in patients with borderline annulus: "stretched better than bigger?"
    Catheter Cardiovasc Interv. 2022;100:422-423.
    >> Share

  306. ZAHID S, Khan MZ, Ullah W, Tanveer Ud Din M, et al
    In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample 2011-2018.
    Catheter Cardiovasc Interv. 2022;100:424-436.
    >> Share

    August 2022
  307. SAGER R, Keller LS, Stehli J, Jakob P, et al
    Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365.
    >> Share

  308. MAURINA M, Condello F, Mangieri A, Sanz-Sanchez J, et al
    Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30385.
    >> Share

  309. OKUNO T, Dangas GD, Hengstenberg C, Sartori S, et al
    Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30370.
    >> Share

  310. SADAT N, Bruhn D, Scharfschwerdt M, Schaller T, et al
    Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30359.
    >> Share

  311. ZAJARIAS A, Kodali S, McCabe JM, Eng MH, et al
    Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30331.
    >> Share

  312. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    >> Share

  313. LIU JD, Zhang SY, Wu YQ, Gong R, et al
    Valve implantation for successful sealing of a balloon predilatation-induced annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 3. doi: 10.1002/ccd.30353.
    >> Share

  314. ISOGAI T, Vanguru HR, Krishnaswamy A, Agrawal A, et al
    Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30340.
    >> Share

  315. KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
    Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
    >> Share

  316. ENG MH, Zahr F
    When should early discharge post-transcatheter aortic valve replacement be blocked?
    Catheter Cardiovasc Interv. 2022;100:254-255.
    >> Share

  317. VETROVEC GW
    Robotic coronary angiography: Advantages of stepping back.
    Catheter Cardiovasc Interv. 2022;100:214-215.
    >> Share

  318. TARANTINI G, Cardaioli F
    Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient.
    Catheter Cardiovasc Interv. 2022;100:243-244.
    >> Share

  319. HELMY T, Mina G
    Single access TAVR. How "minimalist" do we need to be?
    Catheter Cardiovasc Interv. 2022;100:233-234.
    >> Share

    July 2022
  320. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
    >> Share

  321. GALLITTO E, Palmerini T, Saia F, Gargiulo M, et al
    Iliac "paving & cracking" technique for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30344.
    >> Share

  322. SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
    Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
    >> Share

  323. DAUTZENBERG L, van Aarle TTM, Stella PR, Emmelot-Vonk M, et al
    The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2022 Jul 13. doi: 10.1002/ccd.30320.
    >> Share

  324. GALASSI AR, Vadala G, Testa G, Puglisi S, et al
    Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
    >> Share

  325. RUSSO M, Chen C, Sethi A, Hakeem A, et al
    TAVR in an XXXL annulus (1057 mm(2) ) with type I bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2022 Jul 6. doi: 10.1002/ccd.30325.
    >> Share

  326. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    >> Share

  327. ALASNAG M
    Lifetime management when a redo is in the balance: Valve-in-valve transcatheter aortic valve replacement or resurgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022;100:131-132.
    >> Share

  328. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    >> Share

  329. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    >> Share

  330. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    >> Share

    June 2022
  331. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    >> Share

  332. ELZANATY AM, Maraey A, Elbadawi A, Khalil M, et al
    Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2022 Jun 27. doi: 10.1002/ccd.30299.
    >> Share

  333. MEDRANDA GA, Rogers T, Fuery M, Case BC, et al
    Impact of left ventricular outflow tract calcium on valve geometry in self-expanding transcatheter aortic-valve replacement.
    Catheter Cardiovasc Interv. 2022 Jun 20. doi: 10.1002/ccd.30301.
    >> Share

  334. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    >> Share

  335. ARONEY NP, Patterson T, Kalogeropoulos A, Allen CJ, et al
    Clinical outcomes following single access transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30246.
    >> Share

  336. ROBERT P, Akodad M, Lattuca B, Gandet T, et al
    Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.
    Catheter Cardiovasc Interv. 2022 Jun 5. doi: 10.1002/ccd.30248.
    >> Share

  337. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    >> Share

  338. TARANTINI G, Fraccaro C
    Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters.
    Catheter Cardiovasc Interv. 2022;99:2111-2112.
    >> Share

  339. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    >> Share

    May 2022
  340. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Clinical outcomes and predictors in patients with previous cardiac surgery undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30245.
    >> Share

  341. KLEIN LW, Anderson HV, Cigarroa J
    Integrating shared decision-making in coronary revascularization with quality assurance programs.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30222.
    >> Share

  342. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    >> Share

  343. ALACHKAR MN, Muller T, Alnaimi A, Milzi A, et al
    Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real-world cohort.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30238.
    >> Share

  344. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    >> Share

  345. VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
    Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
    >> Share

  346. CORCIONE N, Berni A, Ferraro P, Morello A, et al
    Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30179.
    >> Share

  347. SIMARD T, Reddy YNV, Thaden JJ, Padang R, et al
    Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 10. doi: 10.1002/ccd.30224.
    >> Share

  348. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    >> Share

  349. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    >> Share

  350. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    >> Share

  351. LEE A, Kimmelstiel C
    Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022;99:1750-1751.
    >> Share

  352. POSTALIAN A, Krajcer Z
    Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.
    Catheter Cardiovasc Interv. 2022;99:1817-1818.
    >> Share

  353. TARANTINI G, Cardaioli F
    TAVR and stroke: A common evolution.
    Catheter Cardiovasc Interv. 2022;99:1906-1907.
    >> Share

  354. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    >> Share

  355. SEDHOM R, Megaly M, Saad M, Elbadawi A, et al
    Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
    Catheter Cardiovasc Interv. 2022;99:1859-1866.
    >> Share

  356. TANG GHL, Hooda A, Zaid S, Chuang MY, et al
    Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
    Catheter Cardiovasc Interv. 2022;99:1935-1944.
    >> Share

  357. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    >> Share

  358. VENTURI G, Scarsini R, Pighi M, Kotronias RA, et al
    Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI.
    Catheter Cardiovasc Interv. 2022;99:1925-1934.
    >> Share

  359. MOHANTY BD, Coylewright M, Sequeira AR, Shin D, et al
    Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2.
    Catheter Cardiovasc Interv. 2022;99:1877-1885.
    >> Share

  360. PORAT A, Gordon M, Perlman G, Planer D, et al
    Mass to voltage ratio index predicts mortality following TAVI.
    Catheter Cardiovasc Interv. 2022;99:1918-1924.
    >> Share

  361. ROTTLANDER D, Beucher H, Ghaddioui KA, Boekstegers P, et al
    Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1796-1806.
    >> Share

  362. YA'QOUB L, Gad M, Faza NN, Kunkel KJ, et al
    Sex differences in outcomes of transcatheter edge-to-edge repair with MitraClip: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1819-1828.
    >> Share

  363. ALADIN AI, Case BC, Wermers JP, Rogers T, et al
    Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection.
    Catheter Cardiovasc Interv. 2022;99:1789-1795.
    >> Share

    April 2022
  364. BRUNO F, Elia E, D'Ascenzo F, Marengo G, et al
    Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022 Apr 29. doi: 10.1002/ccd.30219.
    >> Share

  365. MEMON MM, Siddiqui AA, Amin E, Shaikh FN, et al
    Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Apr 27. doi: 10.1002/ccd.30213.
    >> Share

  366. KAWAGUCHI T, Miyoshi T, Hayashi M, Ishizu K, et al
    Efficacy of larger valve sizing with underfilling in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30188.
    >> Share

  367. HOLLOWED J, Akhondi A, Rabbani A, Oncel D, et al
    Single versus double Perclose techniques for vascular closure during transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30176.
    >> Share

  368. BALDETTI L, Beneduce A, Boccellino A, Pagnesi M, et al
    Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30197.
    >> Share

  369. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    >> Share

  370. HOU S, Pan W, Zhou D, Ge J, et al
    Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30203.
    >> Share

  371. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    >> Share

  372. YONG CM, Jaluba K, Batchelor W, Gummipundi S, et al
    Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30182.
    >> Share

  373. INCI E, Block PC
    A little leak goes a long way! 5-Year-outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022;99:1590-1591.
    >> Share

  374. LIU X, Chen Y, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly device.
    Catheter Cardiovasc Interv. 2022;99:1691-1695.
    >> Share

  375. SEGAR MW, Krajcer Z
    Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap.
    Catheter Cardiovasc Interv. 2022;99:1645-1646.
    >> Share

  376. TARANTINI G, Rodino G
    Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone.
    Catheter Cardiovasc Interv. 2022;99:1609-1610.
    >> Share

  377. BRUCE CG, Lederman RJ
    Troubleshooting transcaval access: Honoring our commitments.
    Catheter Cardiovasc Interv. 2022;99:1700-1701.
    >> Share

  378. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    >> Share

  379. RUGE H, Burri M, Erlebach M, Lange R, et al
    Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR.
    Catheter Cardiovasc Interv. 2022;99:1611-1618.
    >> Share

  380. GOLDSWEIG AM, Hermiller JB
    Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
    Catheter Cardiovasc Interv. 2022;99:1597-1598.
    >> Share

    March 2022
  381. SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
    International percutaneous coronary intervention complication survey.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
    >> Share

  382. ZHU Q, Yuan Z, Xu Y, Chen J, et al
    Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30147.
    >> Share

  383. LE RUZ R, Guerin P, Leurent G, Leroux L, et al
    Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30161.
    >> Share

  384. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    >> Share

  385. ESCHENBACH LK, Erlebach M, Deutsch MA, Ruge H, et al
    Stroke after transcatheter aortic valve replacement: A severe complication with low predictability.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30143.
    >> Share

  386. SA MP, Jabagi H, Dokollari A, Awad AK, et al
    Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: Meta-analysis with reconstructed time-to-event data of matched studies.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30162.
    >> Share

  387. SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
    Device entrapment during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
    >> Share

  388. ROTTLANDER D, Golabkesh M, Degen H, Ogutcu A, et al
    Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30157.
    >> Share

  389. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    >> Share

  390. MANO TB, Ramos R, Cacela D, Patricio L, et al
    Not all pseudoaneurysms are femoral-A transcaval transcatheter aortic valve replacement rare complication.
    Catheter Cardiovasc Interv. 2022 Mar 3. doi: 10.1002/ccd.30140.
    >> Share

  391. WINSCOTT JG, Hillegass WB
    Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
    Catheter Cardiovasc Interv. 2022;99:1317-1318.
    >> Share

  392. SPIRITO A, Mehran R
    Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
    Catheter Cardiovasc Interv. 2022;99:979-980.
    >> Share

  393. GILANI S, Jneid H
    Reaching the optimal volume-quality balance in transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:1186-1187.
    >> Share

  394. ENG MH, Fang HK
    Forgotten and unforgiving.
    Catheter Cardiovasc Interv. 2022;99:1287-1288.
    >> Share

  395. SIMPSON TF, Kheiri B, Chadderdon S, Song HK, et al
    TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2022;99:1181-1185.
    >> Share

  396. FABRY N, Hendrickson MJ, Arora S, Vavalle JP, et al
    Five-year trends in cause-specific readmissions and cost burden of mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1251-1256.
    >> Share

  397. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    >> Share

  398. RANARD LS, Vahl TP, Chung CJ, Sadri S, et al
    Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
    Catheter Cardiovasc Interv. 2022;99:1268-1276.
    >> Share

  399. BATLIVALA SP, Hagel JA, Hirsch R, Shahanavaz S, et al
    Transcatheter pulmonary valve-in-valve implantation within the expandable Inspiris Resilia(R) bioprosthetic valve.
    Catheter Cardiovasc Interv. 2022;99:1157-1160.
    >> Share

  400. KANG SL, Ramroop R, Manojlovich L, Runeckles K, et al
    Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
    Catheter Cardiovasc Interv. 2022;99:1138-1148.
    >> Share

  401. ABUSHOUK AI, Saad AM, Isogai T, Shekhar S, et al
    Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1370-1372.
    >> Share

  402. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    >> Share

    February 2022
  403. ASAMI M, Dobner S, Stortecky S, Heg D, et al
    Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Feb 16. doi: 10.1002/ccd.30132.
    >> Share

  404. ELBADAWI A, Tan BE, Sammour Y, Saad M, et al
    Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30072.
    >> Share

  405. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    >> Share

  406. BRUNNER S, Wolfrum M, Moccetti F, Stampfli SF, et al
    The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30114.
    >> Share

  407. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    >> Share

  408. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.
    >> Share

  409. POSTALIAN A, Krajcer Z
    Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction.
    Catheter Cardiovasc Interv. 2022;99:932-933.
    >> Share

  410. GOLDSWEIG AM, Baron SJ
    Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:904-905.
    >> Share

  411. UPADHYAY A, Jneid H
    Predischarge transthoracic echocardiogram after TAVI - Is it really necessary?
    Catheter Cardiovasc Interv. 2022;99:867-868.
    >> Share

  412. O'NEILL BP, Wang DD, Caranasos TG, Chitwood WR Jr, et al
    Initial in-human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices.
    Catheter Cardiovasc Interv. 2022;99:943-948.
    >> Share

  413. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR.
    Catheter Cardiovasc Interv. 2022;99:861-866.
    >> Share

  414. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    >> Share

  415. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    >> Share

    January 2022
  416. ZHOU D, Chen J, Fan J, Yidilisi A, et al
    Self-expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30094.
    >> Share

  417. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    >> Share

  418. OGAMI T, Kurlansky P, Takayama H, Ning Y, et al
    Three-year survival of transcatheter versus surgical aortic valve replacement in dialysis.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30045.
    >> Share

  419. PAULUS MG, Meindl C, Hamerle M, Schach C, et al
    Reduction of radiation exposure during transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30046.
    >> Share

  420. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    >> Share

  421. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    >> Share

  422. YUAN S, He J, Cai Z, Zhang R, et al
    Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30102.
    >> Share

  423. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    >> Share

  424. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    >> Share

  425. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    >> Share

  426. KATO N, Pellikka PA, Scott CG, Lee AT, et al
    Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30093.
    >> Share

  427. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    >> Share

  428. SCHOECHLIN S, Hein M, Brennemann T, Eichenlaub M, et al
    5-Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30083.
    >> Share

  429. FREIXA X, Estevez-Loureiro R, Pascual I, Carrasco-Chinchilla F, et al
    Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30053.
    >> Share

  430. PARAGGIO L, Burzotta F, Graziani F, Aurigemma C, et al
    Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30082.
    >> Share

  431. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    >> Share

  432. ADAMO M, Pagnesi M, Popolo Rubbio A, Branca L, et al
    Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30062.
    >> Share

  433. CHIOU A, Yap J, Russo S, Stripe BR, et al
    Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30066.
    >> Share

  434. CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
    The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
    >> Share

  435. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    >> Share

  436. SIMARD T, Lloyd J, Crestanello J, Thaden JJ, et al
    Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30059.
    >> Share

  437. SIMSEK B, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
    Catheter Cardiovasc Interv. 2022;99:85-87.
    >> Share

  438. OKUYA Y, Moussa ID
    Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!
    Catheter Cardiovasc Interv. 2022;99:169-170.
    >> Share

  439. BELARDI J, Lamelas P
    Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3-years.
    Catheter Cardiovasc Interv. 2022;99:179-180.
    >> Share

  440. UPADHYAY A, Jneid H
    Frailty and malnutrition as influential drivers of outcomes after aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:158-159.
    >> Share

  441. RODRIGUEZ OGANDO A, Ballesteros F, Martinez JLZ
    Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;99:E38-E42.
    >> Share

  442. MOVAHED MR
    Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E43.
    >> Share

    December 2021
  443. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    >> Share

  444. VOGL BJ, Darestani YM, Lilly SM, Thourani VH, et al
    Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 22. doi: 10.1002/ccd.30052.
    >> Share

  445. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    >> Share

  446. OKOH AK, Chen C, Kassotis J, Soliman F, et al
    Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30027.
    >> Share

  447. KORNOWSKI R
    Left main coronary revascularization strategies in the COVID-19 era.
    Catheter Cardiovasc Interv. 2021;98:1262-1263.
    >> Share

  448. KUMAR A, Jneid H
    Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
    Catheter Cardiovasc Interv. 2021;98:1298-1299.
    >> Share

  449. MOUSSA ID
    Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: "There is more to this than meets the eye!"
    Catheter Cardiovasc Interv. 2021;98:1402-1403.
    >> Share

  450. SAIA F
    Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
    Catheter Cardiovasc Interv. 2021;98:1413-1414.
    >> Share

  451. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    >> Share

  452. SCHNEIDER LM, Nicoleta N, Schepperle N, Paukovitsch M, et al
    Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E1000-E1006.
    >> Share

  453. OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
    Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1241-1249.
    >> Share

    November 2021
  454. BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
    Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
    Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
    >> Share

  455. WANG DD, O'Neill BP, Caranasos TG, Chitwood WR Jr, et al
    Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves.
    Catheter Cardiovasc Interv. 2021 Nov 29. doi: 10.1002/ccd.30011.
    >> Share

  456. HOKKEN TW, de Ronde M, Wolff Q, Schermers T, et al
    Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program.
    Catheter Cardiovasc Interv. 2021 Nov 27. doi: 10.1002/ccd.30026.
    >> Share

  457. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    >> Share

  458. GUNARATHNE A, Tan J, Varcoe R, Bhandari S, et al
    The impact of learning-curve-experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all-comers second-generation ACURATE neo transcatheter aortic heart valve registry.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30000.
    >> Share

  459. DAS TM, Shin J, Czarny MJ, Nanavati J, et al
    Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30009.
    >> Share

  460. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    >> Share

  461. NEUSER J, Kempf T, Bauersachs J, Widder JD, et al
    Novel self-expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis.
    Catheter Cardiovasc Interv. 2021 Nov 17. doi: 10.1002/ccd.30003.
    >> Share

  462. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    >> Share

  463. WOLFRUM M, Moccetti F, Piuhola J, Lehtola H, et al
    The Allegra transcatheter heart valve: Short term results from a multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1204-1209.
    >> Share

  464. ENG MH, Abbas AE, Hahn RT, Lee J, et al
    Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)-a propensity matched analysis.
    Catheter Cardiovasc Interv. 2021;98:1185-1192.
    >> Share

  465. ORVIN K, Perl L, Landes U, Dvir D, et al
    Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry.
    Catheter Cardiovasc Interv. 2021;98:E862-E869.
    >> Share

  466. DE MARCO F, Casenghi M, Spagnolo P, Popolo Rubbio A, et al
    A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.
    Catheter Cardiovasc Interv. 2021;98:E847-E854.
    >> Share

  467. RAZUK V, Camaj A, Cao D, Nicolas J, et al
    Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2021;98:E870-E880.
    >> Share

  468. NAZIR S, Ahuja KR, Ariss RW, Hassanein M, et al
    Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.
    Catheter Cardiovasc Interv. 2021;98:E839-E846.
    >> Share

  469. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
    Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
    >> Share

  470. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    >> Share

  471. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    >> Share

  472. REILLY JP, Parikh PB
    Valve-in-valve transcatheter aortic valve replacement versus re-do surgical aortic valve replacement: A call for randomized controlled trials.
    Catheter Cardiovasc Interv. 2021;98:948-949.
    >> Share

  473. ARSLAN F, Gerckens U
    Virtual support for remote proctoring in TAVR during COVID-19.
    Catheter Cardiovasc Interv. 2021;98:E733-E736.
    >> Share

  474. BAGUR R, Jneid H
    Coronary artery access after aortic valve intervention.
    Catheter Cardiovasc Interv. 2021;98:957-958.
    >> Share

  475. KIM JY, Kim SH, Jang SI
    Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;98:923-927.
    >> Share

  476. LE RUZ R, Plessis J, Houeijeh A, Baruteau AE, et al
    Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-year follow-up in a French Registry.
    Catheter Cardiovasc Interv. 2021;98:990-999.
    >> Share

  477. LEE SY, Kim GB, Kim SH, Jang SI, et al
    Mid-term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021;98:E724-E732.
    >> Share

  478. KAPLE RK, Agarwal V, Azarbal A, Sugeng L, et al
    Tricuspid clip implantation using the MitraClip system-A step-by-step guide.
    Catheter Cardiovasc Interv. 2021;98:1006-1019.
    >> Share

  479. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    >> Share

  480. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    >> Share

    October 2021
  481. AMIN R, Arunothayaraj S, Kirtchuk D, Williams T, et al
    Mobility aids predict mortality after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Oct 22. doi: 10.1002/ccd.29981.
    >> Share

  482. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    >> Share

  483. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    >> Share

  484. STANOVA V, Rieu R, Cote N, Salaun E, et al
    In vitro Doppler versus catheter transvalvular pressure gradients in balloon-expandable versus self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2021 Oct 11. doi: 10.1002/ccd.29974.
    >> Share

  485. TANG GHL, Sengupta A, Alexis SL, Zaid S, et al
    Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy.
    Catheter Cardiovasc Interv. 2021 Oct 9. doi: 10.1002/ccd.29973.
    >> Share

  486. MATSUMOTO S, Ohno Y, Miyamoto J, Ikari Y, et al
    Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021 Oct 6. doi: 10.1002/ccd.29960.
    >> Share

  487. MUSUMECI G, Annibali G
    Transcarotid access as a first alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021;98:774-775.
    >> Share

  488. OKUYA Y, Moussa ID
    Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
    Catheter Cardiovasc Interv. 2021;98:786-787.
    >> Share

  489. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    >> Share

  490. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    >> Share

  491. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    >> Share

  492. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    >> Share

  493. BRINKMANN C, Abdel-Wahab M, Bedogni F, Bhadra OD, et al
    Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study.
    Catheter Cardiovasc Interv. 2021;98:756-764.
    >> Share

  494. GARCIA-SAYAN E, Raghunathan D, Li FM, Dhoble A, et al
    Initial experience with the fourth generation MitraClip: Outcomes, procedural aspects, and considerations for device selection.
    Catheter Cardiovasc Interv. 2021;98:E626-E636.
    >> Share

  495. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    >> Share

    September 2021
  496. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    >> Share

  497. ELBADAWI A, Mahta D, Elgendy IY, Dang AT, et al
    Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2021 Sep 27. doi: 10.1002/ccd.29963.
    >> Share

  498. LEE DU, Han J, Fan GH, Hastie DJ, et al
    The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011-2017 US hospital database.
    Catheter Cardiovasc Interv. 2021 Sep 25. doi: 10.1002/ccd.29952.
    >> Share

  499. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    >> Share

  500. ALKHOULI M, Jneid H
    Optimal management of acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2021;98:613-614.
    >> Share

  501. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    >> Share

  502. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    >> Share

  503. PETRI N, Lengenfelder B, Voelker W, Nordbeck P, et al
    Interventional closure of aortomitral perforation after TAVR: A case report.
    Catheter Cardiovasc Interv. 2021;98:E483-E485.
    >> Share

  504. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    >> Share

  505. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    >> Share

  506. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    >> Share

    August 2021
  507. BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
    Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
    >> Share

  508. GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
    Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
    >> Share

  509. MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
    Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
    Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
    >> Share

  510. GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
    Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
    >> Share

  511. BELARDI JA, Lamelas PM
    New TAVR item added to cart for large scale clinical testing.
    Catheter Cardiovasc Interv. 2021;98:380-381.
    >> Share

  512. POSTALIAN A, Krajcer Z
    Individualizing risk assessment for conduction system injury after alcohol septal ablation.
    Catheter Cardiovasc Interv. 2021;98:401-402.
    >> Share

  513. FRANZONE A, Esposito G
    Transcatheter aortic valve thrombosis: The more we see the more we know.
    Catheter Cardiovasc Interv. 2021;98:363-364.
    >> Share

  514. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    >> Share

  515. GRINES CL, Klein AJ, Bauser-Heaton H, Alkhouli M, et al
    Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.
    Catheter Cardiovasc Interv. 2021;98:277-294.
    >> Share

  516. RIMMAUDO F, Angelini G, Condello I
    Thrombocytopenia after TAVI in patients with low body mass index.
    Catheter Cardiovasc Interv. 2021;98:E329-E331.
    >> Share

  517. KREUTZER J, Armstrong AK, Rome JJ, Zellers TM, et al
    Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
    Catheter Cardiovasc Interv. 2021;98:E262-E274.
    >> Share

  518. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    >> Share

  519. QURESHI WT, Parker M, Walker J, Kakouros N, et al
    Equipment entrapment during redo-TAVR with successful BASILICA procedure.
    Catheter Cardiovasc Interv. 2021;98:E320-E323.
    >> Share

  520. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    >> Share

  521. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    >> Share

  522. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    >> Share

    July 2021
  523. STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
    Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
    >> Share

  524. VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
    Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
    >> Share

  525. URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
    Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
    Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
    >> Share

  526. OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
    Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
    >> Share

  527. CILINGIROGLU M, Okutucu S
    TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility.
    Catheter Cardiovasc Interv. 2021;98:168-169.
    >> Share

  528. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    >> Share

  529. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    >> Share

  530. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    >> Share

  531. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    >> Share

  532. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    >> Share

    June 2021
  533. ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
    Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
    Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
    >> Share

  534. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
    >> Share

  535. NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
    Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
    Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
    >> Share

  536. SALEEM S, Ullah W, Syed MA, Megaly M, et al
    Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
    >> Share

  537. GRINES CL, Leach C
    Acute myocardial infarction related cardiogenic shock: How important is vascular access site?
    Catheter Cardiovasc Interv. 2021;97:1367-1368.
    >> Share

  538. COSTELLO BT, Krajcer Z
    Editorial Comments for: "Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis".
    Catheter Cardiovasc Interv. 2021;97:1479-1480.
    >> Share

  539. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    >> Share

  540. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    >> Share

  541. IMAMURA T, Narang N
    Improving clinical outcomes following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:E1053.
    >> Share

    May 2021
  542. LIM DS, Smith RL, Zahr F, Dhoble A, et al
    Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
    >> Share

  543. LIU X, Pu Z, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
    >> Share

  544. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    >> Share

  545. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    >> Share

  546. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    >> Share

  547. BELHAJ SOULAMI R, Castro M, Haigron P, Verhoye JP, et al
    Computer-assisted valve in valve in a deteriorated Mosaic valve using a library of bioprostheses.
    Catheter Cardiovasc Interv. 2021;97:E893-E896.
    >> Share

  548. SAAD AM, Kassis N, Gad MM, Abdelfattah O, et al
    Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis.
    Catheter Cardiovasc Interv. 2021;97:1252-1256.
    >> Share

  549. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    >> Share

  550. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    >> Share

  551. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    >> Share

    April 2021
  552. MORENO R, Baz JA, Moreu J, Berenguer A, et al
    Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
    Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
    >> Share

  553. CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
    Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
    Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
    >> Share

  554. MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
    Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
    >> Share

  555. OKUNO T, Heg D, Lanz J, Praz F, et al
    Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
    >> Share

  556. PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
    In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
    >> Share

  557. COSTA G, D'Errigo P, Rosato S, Valvo R, et al
    Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
    >> Share

  558. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    >> Share

  559. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    >> Share

  560. IRIART X, Guerin P, Jalal Z, Thambo JB, et al
    Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
    >> Share

    March 2021
  561. BOEDER NF, Bayer M, Dorr O, Nef HM, et al
    Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
    >> Share

  562. KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
    Elective versus urgent in-hospital transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
    >> Share

  563. KITAMURA M, Fam NP, Braun D, Ruf T, et al
    12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
    >> Share

    February 2021
  564. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    >> Share

  565. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    >> Share

  566. HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
    Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
    >> Share

  567. SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
    Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
    >> Share

  568. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    >> Share

  569. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
    >> Share

    January 2021
  570. MYAT A, Mouy F, Buckner L, Cockburn J, et al
    Survival relative to pacemaker status after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
    >> Share

  571. QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
    Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
    Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
    >> Share

  572. MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
    Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
    Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
    >> Share

  573. NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
    The effect of transcatheter aortic valve implantation approaches on mortality.
    Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
    >> Share

    December 2020
  574. TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
    Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
    Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
    >> Share

  575. ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
    Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
    >> Share

  576. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    >> Share

  577. AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
    Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
    >> Share

    November 2020
  578. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    >> Share

  579. BAEKKE PS, Jorgensen TH, Sondergaard L
    Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
    >> Share

  580. SUGIURA A, Weber M, Tabata N, Goto T, et al
    Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
    >> Share

  581. BENETOS G, Karmpalioti M, Drakopoulou M, Stathogiannis K, et al
    One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29389.
    >> Share

  582. ALARFAJ M, Jain T, Krepp J
    Transcatheter mitral valve thrombosis: A case report and literature review.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
    >> Share

  583. SAYAH N, Simon F, Garceau P, Ducharme A, et al
    Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
    >> Share

  584. CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
    One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
    Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
    >> Share

    October 2020
  585. ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
    Contemporary transcatheter aortic valve implantation related thrombocytopenia.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
    >> Share

  586. KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
    Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
    >> Share

    September 2020
  587. HOSHI T, Hiraya D, Sato A, Ieda M, et al
    Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
    >> Share

  588. MORITA Y, Endo A, Tanabe K
    Papillary muscle rupture after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29252.
    >> Share

  589. HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
    Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
    >> Share

  590. IMAMURA T
    How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
    >> Share

  591. SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
    Carotid access for transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
    >> Share

    August 2020
  592. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
    >> Share

  593. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    >> Share

  594. KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
    Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
    >> Share

  595. BIANCARI F, Pykari J, Savontaus M, Laine M, et al
    Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
    >> Share

    July 2020
  596. YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
    Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
    >> Share

  597. RAHEJA H, Ahuja KR, Nazir S, Saad AM, et al
    Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2020 Jul 23. doi: 10.1002/ccd.29129.
    >> Share

  598. SHEIKH MA, Deo SV, Riaz H, Raza S, et al
    Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
    >> Share

  599. SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
    Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
    >> Share

  600. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    >> Share

  601. COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
    Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
    >> Share

  602. COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
    Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
    Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
    >> Share

    June 2020
  603. ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
    Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
    >> Share

  604. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    >> Share

  605. MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
    Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
    >> Share

  606. SATHANANTHAN J, Green P, Finn M, Wood DA, et al
    Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
    >> Share

  607. TANG L, Sorajja P, Mooney M, Garberich R, et al
    Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
    >> Share

  608. MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
    Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
    >> Share

    May 2020
  609. SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
    Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
    Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
    >> Share

  610. LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
    Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
    >> Share

  611. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    >> Share

    April 2020
  612. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    >> Share

  613. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    >> Share

    February 2020
  614. DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
    Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
    Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
    >> Share

    January 2020
  615. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    >> Share

    December 2019
  616. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    >> Share

    November 2019
  617. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016